학술논문
209P Trastuzumab plus lapatinib or chemotherapy in patients with HER2-positive advanced breast cancer refractory to anti-HER2 therapies: A randomized, multicenter, phase II trial (GIM12-TYPHER)
Document Type
Abstract
Author
Source
In ESMO Open May 2023 8(1) Supplement 4
Subject
Language
ISSN
2059-7029